Efficacy of Penile Traction Therapy Using a Novel Device
Penile Diseases
About this trial
This is an interventional basic science trial for Penile Diseases
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of Peyronie's disease
- Current 30 degree curvature in a single plane (i.e. 20 degrees up, 15 degrees left would not be a candidate)
- Not undergoing other therapies for PD currently
Exclusion Criteria:
- Stretched penile length <7 cm
- Prisoners
- Erectile dysfunction unresponsive to phosphodiesterase-5 inhibitors or intracavernosal injection therapies
- Diabetes mellitus with evidence of end-organ damage (peripheral neuropathy, retinopathy, chronic kidney disease stage III or higher)
Sites / Locations
- Mayo Clinic
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Sham Comparator
Experimental
Experimental
Experimental
Group 1 - Control
Group 2 - PTT 1x daily x 3 months
Group 3 - PTT 2x daily x 3 months
Group 4 - PTT 3x daily x 3 months
No treatment will be administered for the initial 3 months. This are is necessary as Peyronie's disease may result in changes in length and curvature as a function of the disease process. After the 3 month period of time, this group will enter an open label phase where they may utilize a penile traction device if desired.
Men will utilize penile traction therapy for 30 minutes once daily for the initial 3 months. After this phase is completed, they will enter an open label phase for 3 months where they may utilize the device as much or as little as desired.
Men will utilize penile traction therapy for 30 minutes twice daily for the initial 3 months. After this phase is completed, they will enter an open label phase for 3 months where they may utilize the device as much or as little as desired.
Men will utilize penile traction therapy for 30 minutes three times daily for the initial 3 months. After this phase is completed, they will enter an open label phase for 3 months where they may utilize the device as much or as little as desired.